1. Paediatric obesity and Crohn's disease: a descriptive review of disease phenotype and clinical course.
- Author
-
McCoy, Jacob, Miller, Michael R, Watson, Melanie, Crowley, Eileen, and Woolfson, Jessica P
- Subjects
DIARRHEA ,WEIGHT loss ,CROHN'S disease ,BODY mass index ,GASTROINTESTINAL hemorrhage ,SCIENTIFIC observation ,ABDOMINAL pain ,TREATMENT effectiveness ,RETROSPECTIVE studies ,DESCRIPTIVE statistics ,RESEARCH methodology ,CHILDHOOD obesity ,ANTHROPOMETRY ,PHENOTYPES ,DISEASE progression ,CHILDREN - Abstract
Objectives In an era of increasing paediatric obesity and inflammatory bowel disease (IBD), this study evaluates the disease phenotype and clinical course of Crohn's disease (CD) in paediatric patients who are obese or overweight. Methods This is a retrospective, single-center, descriptive observational study from January 2010 to May 2020. Participants were included if they were: aged 2 to 18 years at the time of diagnosis, had a confirmed diagnosis of CD, and met WHO criteria for overweight or obesity at the time of diagnosis or within one year before diagnosis. Results A total of 345 patient charts with CD were screened during the study period, with 16 patients meeting inclusion criteria. Median age of patients was 15.5 years (IQR = 13.6, 16.1). Of the 15 patients over 10 years of age, median anthropometrics at diagnosis included body mass index (BMI) of 27.2 (IQR = 24.9, 29.4) and BMI for age z-score of 1.82 (IQR = 1.58, 2.19). Presenting symptoms included abdominal pain (80.0%), diarrhea (66.7%), hematochezia (66.7%), and weight loss (26.7%). Five patients (33.3%) had obesity-related complications. Median time from symptom onset to diagnosis was 146 days (IQR = 31, 367), and median time from diagnosis to remission was 229 days (IQR = 101.8, 496.3). Conclusions Patients with elevated BMI and CD present with typical symptoms of IBD, although weight loss was a less common presenting symptom. Time to disease remission is delayed, and obesity-related complications are common. Primary care providers must have a high degree of clinical suspicion in patients to prevent delays to gastroenterology referral and to improve time to disease remission. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF